Skip to main content

Table 1 Hemodynamic and respiratory variables in anesthetized pigs subjected to Zone I resuscitative endovascular balloon occlusion of the aorta for 15 (REBOA15), 30 (REBOA30), 60 min (REBOA60) and control conditions (no occlusion) and reperfusion for 3 h (n = 6 per group)

From: Total resuscitative endovascular balloon occlusion of the aorta causes inflammatory activation and organ damage within 30 minutes of occlusion in normovolemic pigs

Variables

Baseline

End of intervention

15 min reperfusion

1 h reperfusion

2 h reperfusion

3 h reperfusion

Heart rate (beats min−1)

 Control

106 (91–121)

102 (85–120)bcd

103 (86–120)bcd

102 (83–122)b

99 (80–117)

96 (78–114)

 REBOA15

120 (78–162)

209 (185–232)a

169 (156–181)a

152 (119–185)a

131 (93–170)

128 (98–159)

 REBOA30

110 (90–129)

213 (196–230)a

171 (145–198)a

139 (109–170)

126 (97–155)

129 (110–149)

 REBOA60

122 (65–179)

190 (168–212)a

157 (125–189)a

133 (100–166)

136 (101–172)

140 (100–181)

SBP (mmHg)

 Control

102 (97–106)

96 (84–107)bcd

98 (89–106)

95 (83–107)

91 (80–102)

88 (76–99)

 REBOA15

94 (79–110)

194 (136–252)ad

106 (91–121)

92 (77–106)

95 (82–109)

94 (82–105)

 REBOA30

97 (80–114)

170 (140–200)a

108 (85–131)d

84 (75–94)

86 (77–95)

89 (69–108)

 REBOA60

96 (91–101)

146 (128–164)ab

80 (65–95)c

81 (75–88)

85 (81–89)

91 (78–104)

CO (l min−1)

 Control

4.9 (3.7–6.1)

4.6 (3.6–5.6)bc

4.5 (3.5–5.6)

4.4 (3.4–5.3)

4.3 (3.5–5.1)

4.3 (3.4–5.1)

 REBOA15

4.9 (3.8–6.1)

6.1 (5.4–6.8)ad

5.8 (4.4–7.1)d

4.8 (3.7–5.9)

4.7 (3.5–5.8)

4.5 (3.6–5.4)

 REBOA30

4.7 (3.7–5.6)

6.1 (5.5–6.8)ad

5.4 (4.7–6.1)d

4.5 (3.6–5.4)

4.1 (3.4–4.8)

4.3 (3.5–5.0)

 REBOA60

4.1 (3.2–4.9)

4.2 (3.8–4.7)bc

3.8 (2.7–4.9)bc

3.7 (3.0–4.3)

3.4 (2.9–4.0)

3.3 (2.6–3.9)

SMA blood flow (ml min−1)

 Control

797 (605–990)

771 (614–928)bcd

755 (617–893)

734 (581–886)

709 (530–887)

704 (515–894)

 REBOA15

747 (479–1015)

35 (18–52)a

910 (654–1165)

873 (565–1180)

830 (439–1220)

784 (451–1117)

 REBOA30

731 (434–1027)

17 (9–24)a

915 (691–1138)

772 (528–1016)

733 (520–946)

687 (467–907)

 REBOA60

642 (458–826)

21 (10–33) a

617 (305–929)

723 (479–967)

633 (487–780)

572 (408–736)

Femoral blood flow (ml min−1)

 Control

266 (147–386)

228 (116–341)bcd

225 (105–345)

212 (110–313)

207 (116–297)

199 (111–286)

 REBOA15

287 (203–371)

14 (1–26)a

242 (97–387)

234 (110–358)

204 (94–315)

199 (95–303)

 REBOA30

347 (181–513)

19 (2–35)a

328 (172–483)

280 (175–384)

256 (180–333)

243 (168–317)

 REBOA60

289 (178–400)

15 (−4–34)a

221 (55–386)

176 (79–272)

149 (39–259)

169 (47–291)

ETCO2 (%)

 Control

5.0 (4.7–5.3)

4.7 (4.2–5.1)bcd

4.6 (4.3–4.9) c

4.6 (4.3–4.9)

4.6 (4.1–5.0)

4.4 (4.0–4.7)

 REBOA15

4.9 (4.6–5.1)

3.5 (3.2–3.8)a

5.0 (4.7–5.2)b

4.9 (4.6–5.3)

4.9 (4.8–5.0)

4.6 (4.2–4.9)

 REBOA30

4.9 (4.5–5.3)

3.4 (3.0–3.8)a

5.8 (5.2–6.5)abd

5.1 (4.5–5.7)

4.7 (4.4–5.0)

4.7 (4.3–5.1)

 REBOA60

4.7 (4.5–4.9)

2.9 (2.3–3.6)a

4.8 (3.8–5.7)c

4.6 (3.8–5.4)

4.6 (4.0–5.1)

4.5 (3.4–5.5)

FiO2 (%)

 Control

26 (23–29)

26 (23–29)

28 (25–30)

28 (25–30)

28 (25–30)

28 (26–30)

 REBOA15

25 (23–27)

26 (24–28)

27 (23–31)

27 (24–31)

28 (23–32)

27 (23–31)

 REBOA30

26 (22–29)

26 (23–29)

26 (22–29)

26 (22–29)

28 (22–33)

28 (23–34)

 REBOA60

29 (23–35)

29 (21–36)

29 (22–36)

30 (24–36)

29 (25–33)

29 (24–33)

PaO2/FiO2

 Control

64 (57–71)

61 (53–69)d

64 (58–69)

64 (58–71)

67 (63–72)

66 (63–70)

 REBOA15

64 (56–72)

71 (63–79)

64 (54–75)

66 (60–71)

65 (54–76)

68 (57–79)

 REBOA30

66 (61–71)

73 (66–79)

57 (49–65)

60 (55–65)

68 (62–75)

67 (61–73)

 REBOA60

71 (60–81)

73 (64–83)a

64 (53–75)

69 (59–80)

69 (62–76)

67 (58–76)

Mesenteric oxygen uptake VO2 (ml O2 min−1)

 Control

41 (26–56)

36 (18–53)bcd

 

37 (27–46)

 

35 (23–47)

 REBOA15

36 (27–46)

3.6 (1.0–6.3)a

 

38 (25–52)

 

29 (10–48)

 REBOA30

29 (13–44)

1.7 (1.0–2.4)a

 

35 (2.5–67)

 

31 (5.7–56)

 REBOA60

28 (17–40)

2.0 (1.0–2.9)a

 

24 (10–38)

 

23 (17–29)

  1. Data are means (95% confidence interval). SBP Systolic arterial blood pressure, CO Cardiac output, SMA Superior mesenteric artery, ETCO2 End-tidal carbon dioxide, FiO2 Fraction of inspired oxygen, PaO2 arterial partial pressure of oxygen, VO2 Oxygen uptake
  2. a Statistically significant difference compared to controls
  3. b Statistically significant difference compared to REBOA 15 min
  4. c Statistically significant difference compared to REBOA 30 min
  5. d Statistically significant difference compared to REBOA 60 min